Int roduct ion: Ischemic st roke is t he leading cause of mort alit y in Port ugal, wit h around 30 t o 50 % of cases being of cardioembolic et iology. Transesophageal echocardiography (TEE) has assumed growing import ance in t he det ect ion of cardiac sources of embolism. However, t here is cont roversy regarding t he implicat ions of TEE fi ndings for t he t herapeut ic approach t o pat ient s wit h ischemic st roke. Obj ect ives: To analyze TEE fi ndings in t he diagnost ic work-up of pat ient s wit h ischemic cerebral event s and t o det ermine t heir infl uence on t herapeut ic st rat egy. Met hods: We ret rospect ively st udied pat ient s wit h st roke or t ransient ischemic at t ack (TIA) before t he age of 65, of no apparent cause aft er carot id ult rasound, elect rocardiogram and t ranst horacic echocardiography, who underwent TEE bet ween 1992 and 2009. The following diagnoses on TEE were considered as pot ent ial embolic sources: at rial sept al defect ; pat ent foramen ovale (PFO); at rial sept al aneurysm (ASA); veget at ions; t umors; int racavit ary t hrombi; and aort ic plaques >2 mm (ascending aort a and arch). Result s: We analyzed 294 pat ient s, mean age 45 years, 56.8 % men. TEE revealed a pot ent ial cardioembolic source in 36.7 % of t he pat ient s, PFO and ASA being t he most frequent . Throughout t he period considered, t here was an increase in t he number of exams performed, as well as in diagnoses, mainly PFO and ASA. Comparison of pat ient s wit h and wit hout a diagnosis on TEE showed t hat t he former were older and were more oft en prescribed oral ant icoagulat ion. By mult ivariat e analysis, t he presence of a posit ive TEE fi nding was shown t o be an independent predict or of t reat ment wit h oral ant icoagulat ion (OR=2.48; CI 95 %: 1.42-4.34; p=0.001). Conclusion: In t he populat ion under analysis, TEE was useful in ident ifying pot ent ial cardioembolic sources and infl uenced t he t herapeut ic st rat egy.
Introduction
St roke is a maj or cause of morbidit y and mort alit y worldwide 1 , and is t he leading cause of mort alit y in Port ugal, affect ing t wo t o t hree people every hour according t o t he Port uguese St roke Societ y 2 .
Around 80 % of st rokes are ischemic, of which 30-50 % are of cardioembolic et iology [3] [4] [5] .
Transesophageal echocardiography (TEE) has been shown t o be superior t o t ranst horacic echocardiography (TTE) in det ect ing cardioembolic sources, as it provides bet t er visualizat ion of post erior cardiac st ruct ures (left at rium and left at rial appendage) and t he t horacic aort a, which are import ant sources of syst emic embolism 6, 7 . Despit e t he recognit ion of TEE's diagnost ic superiorit y, some aut hors st ill quest ioned it s usefulness in t he t herapeut ic management of pat ient s wit h st roke or t ransient ischemic at t ack (TIA) 8 . However, more recent st udies have shown t hat TEE fi ndings infl uence t herapeut ic st rat egy 4, 9 . Long-t erm t reat ment opt ions following an ischemic cerebral event are ant icoagulat ion or single or dual ant iplat elet t herapy. Given t he different risk/ benefi t profi les of t he available t herapies, t he select ed t reat ment should provide t he great est possible prot ect ion wit h t he lowest associat ed bleeding risk. However, t here is st ill cont roversy as t o t he most appropriat e t reat ment in cert ain sit uat ions, such as complex aort ic at heromas and pat ent foramen ovale (PFO), for which t here are as yet no evidence-based t herapeut ic st rat egies 4 . The significance of some diagnost ic findings from TEE in t erms of t herapeut ic management is t hus unclear.
The result s of t wo Port uguese st udies, by Cabral et al. and Timót eo et al. 10, 11 , on t he role of TEE in t he diagnost ic assessment of pat ient s wit h ischemic event s are in agreement wit h t hose of ot her leading aut hors. However, neit her st udy analyzed t he influence of TEE findings on subsequent t herapeut ic management of t he pat ient s.
Objectives
Our aim was t o analyze pat ient s wit h st roke and/ or TIA before t he age of 65 of no apparent cause aft er carot id ult rasound (or ot her exams assessing t he carot id art eries), ECG and TTE, who underwent TEE for det ect ion of a cardioembolic source. TEE findings (undet ect ed or inconclusive by TTE) were charact erized and t heir infl uence on subsequent t herapeut ic management was det ermined
Papel do ecocardiograma transesofágico na avaliação e orientação terapêutica dos doentes com evento cerebral isquémico agudo até aos 65 anos de idade
Int rodução: O acident e vascular cerebral (AVC) isquémico é a principal causa de mort e em Port ugal, est imando-se que cerca de 30 a 50 % dos casos sej am de et iologia embólica cardíaca. O ecocardiograma t ransesofágico (ETE) t em assumido um papel cada vez mais import ant e na ident ifi cação de pot enciais font es cardíacas de embolização. No ent ant o, o seu papel na orient ação t erapêut ica t em sido mais cont roverso. Obj ect ivos: Analisar os dados obt idos pelo ETE na avaliação diagnóst ica dos doent es int ernados com AVC, assim como a infl uência dos mesmos na orient ação t erapêut ica. Mét odos: Est udo ret rospect ivo de doent es com AVC ou acident e isquémico t ransit ório (AIT) at é aos 65 anos, sem diagnóst ico após ecodoppler dos vasos do pescoço, elect rocardiograma (ECG) e ecocardiograma t ranst orácico (ETT), submet idos à realização de ETE ent re 1992 e 2009. Relat ivament e aos achados do ETE, foram considerados como pot enciais font es embólicas os seguint es diagnóst icos: defeit o do sept o int erauricular (SIA) ou comunicação int erauricular; f oramen ovale pat ent e (FOP); aneurisma do SIA (ASIA); veget ação; t rombo int racavit ário; t umor; placas aórt icas > 2 mm (aort a ascendent e e arco). Result ados: Foram avaliados 294 doent es com idade média de 45 anos, sendo 56,8 % do sexo masculino. O ETE diagnost icou pot enciais font es embólicas cardíacas em 36,7 % dos casos, sendo o FOP e o ASIA os diagnóst icos mais frequent es. Ao longo do período avaliado, verifi cou-se um aument o do número de exames realizados assim como do número de diagnóst icos, principalment e de FOP e ASIA. Quando comparados os doent es com achado diagnóst ico no ETE com os rest ant es, verifi cou-se que os primeiros eram mais idosos e mais frequent ement e medicados com hipocoagulação oral. At ravés de análise mult ivariada, a presença de um achado diagnóst ico no ETE foi confi rmada como predit or independent e da inst it uição de hipocoagulação oral (OR = 2,48; IC 95 %: 1,42-4,34; p = 0,001). Conclusão: Na população avaliada, o ETE revelou-se út il na pesquisa de pot enciais font es embólicas cardíacas e infl uenciou a subsequent e orient ação t erapêut ica.
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Hipocoagulação oral by comparing pat ient s wit h and wit hout pot ent ial embolic sources on TEE.
Methods
We ret rospect ively analyzed 294 pat ient s who underwent TEE in an 18-year period (1992 t o 2009) in t he echocardiographic laborat ory at Braga Hospit al for invest igat ion of a cardioembolic source as t he cause of st roke and/ or TIA. Inclusion crit eria were a confirmed diagnosis of st roke and/ or TIA (by imaging st udy and/ or clinical assessment ) and age under 65. Exclusion crit eria were at rial fi brillat ion (ident ified on ECG or Holt er monit oring), >50 % carot id st enosis by carot id ult rasound, angiography or magnet ic resonance angiography (all pat ient s underwent at least one of t hese diagnost ic exams), or a clear diagnost ic finding on TTE. Cert ain fi ndings on TTE (including suspect ed PFO or at rial sept al aneurysm [ASA]) were not conclusive, t hus prompt ing assessment by TEE.
Demographic, clinical, laborat ory and echocardiographic dat a were obt ained from comput erized and/ or paper-based medical records.
All TEE exams were performed in t he echocardiographic laborat ory of Braga Hospit al's cardiology depart ment . Various ult rasound syst ems were used during t he period under analysis (1992-2009), in chronological order: Hewlet t Packard Sonos 2000, Acuson Sequoia C256, and Philips iE33 (t he lat est , in use since 2007, equipped wit h a S7-2 Omni t ransducer).
All exams were performed aft er six hours' fast ing wit h t he pat ient in left lat eral decubit us. To reduce t he discomfort of t he exam, a 5 mg dose of diazepam was usually administ ered sublingually and lidocaine gel was applied t o facilit at e int roduct ion of t he probe int o t he oropharynx. Int racardiac shunt s were invest igat ed using int ravenous inj ect ion of agit at ed saline solut ion during t he Valsalva maneuver.
The following fi ndings on TEE (t oget her wit h defi nit ions when appropriat e) were considered pot ent ial embolic sources:
• At rial sept al defect (ASD) -any solut ion of cont inuit y in t he int erat rial sept um (IAS); • Pat ent foramen ovale -int erat rial shunt (flow) at t he level of t he fossa ovalis in t he apparent absence of a solut ion of cont inuit y at t his level or t he presence of a t unnel-like solut ion of cont inuit y charact erist ic of PFO, document ed by Doppler and/ or agit at ed saline solut ion t est (inj ect ed via an arm vein, ideally at t he elbow, wit h passage of at least one bubble t o t he left at rium following t he Valsalva maneuver wit hin t hree cardiac cycles aft er opacifi cat ion of t he right at rium) 12 ; • At rial sept al aneurysm -excursion of t he mid port ion of t he IAS by at least 10 mm beyond t he sept al plane (t owards one or ot her of t he at ria depending on variat ions in at rial pressures during t he cardiac cycle) 13 ; • Veget at ions; • Int racavit ary t hrombus; • Tumor;
• Aort ic plaques of >2 mm (ascending aort a and arch). This figure was used since it was not possible t o accurat ely quant ify plaques of >2 mm; however, while plaques of >4 mm are st rongly associat ed wit h ischemic cerebral event s, smaller plaques have also been linked t o increased risk for st roke or TIA 14 .
Statistical analysis
The chi-square t est was used t o compare cat egorical variables (expressed in percent ages). Cont inuous variables (expressed as means ± st andard deviat ion) were compared using t he St udent 's t t est when t hey present ed a normal dist ribut ion, and t he Mann-Whit ney t est ot herwise.
Mult ivariat e logist ic regression analysis was used t o ident ify t he variables independent ly associat ed wit h t reat ment wit h oral ant icoagulat ion. A value of p <0.05 was considered st at ist ically signifi cant .
Results
The baseline charact erist ics of t he pat ient s undergoing TEE are shown in Table 1 .
Mean age was 45±10 years, and 56.8 % were male. The ischemic event was st roke in 80.6 % of t he pat ient s. Wit h regard t o cardiovascular risk fact ors (diabet es, hypert ension, dyslipidemia and smoking), 61.2 % had at least one risk fact or, hypert ension being t he most common (in 32.7 %).
TEE findings are list ed in Table 2 , which shows t hat a pot ent ial cardioembolic source was det ect ed in 36.7 % of t he pat ient s, t he most common being PFO (20.1 %) and ASA (16.7 %), while 10.5 % had bot h.
There was a signifi cant increase in t he number of exams performed (85 vs. 209) in t he second half of t he st udy period, as well as in t he percent age of exams det ect ing a pot ent ial embolic source, mainly cases of PFO and ASA.
Of t he pat ient s wit h PFO (n=59), 52.5 % also present ed ASA, and 13.6 % were referred for percut aneous PFO closure; t hree-quart ers of t he lat t er also had ASA and most were referred in t he last fi ve years of t he st udy period.
Comparison of pat ient s wit h and wit hout a posit ive TEE fi nding (undet ect ed or inconclusive by TTE) ( Table 3) showed t hat t he former were older, wit h no signifi cant differences in ot her baseline charact erist ics. Pat ient s wit h posit ive TEE were more oft en t reat ed wit h oral ant icoagulat ion. Mult ivariat e logist ic regression analysis, adj ust ed for possible confounding variables, showed t hat t he presence of a posit ive TEE fi nding was an independent predict or of t reat ment wit h oral ant icoagulat ion (Table 4 ). Only one pat ient was cont raindicat ed for t his t reat ment , due t o a hist ory of int racranial hemorrhage.
Discussion
TEE revealed a pot ent ial cardioembolic source in 36.7 % of t he st udy populat ion, PFO and ASA being t he most common (20.1 and 16.7 %, respect ively), t he t wo anomalies oft en being associat ed (in 10.5 % of pat ient s). These result s are in agreement wit h t hose of ot her st udies, including recent ones 2, 15 .
There was a significant increase t hroughout t he st udy period in t he number of exams performed as well as in diagnoses of pot ent ial cardioembolic sources (in bot h relat ive and absolut e t erms), mainly cases of PFO and ASA. These result s are in agreement wit h t hose of Timót eo et al. 10 , refl ect ing bot h more widespread availabilit y of TEE as a met hod t o screen for pot ent ial cardiac sources for syst emic embolism and great er diagnost ic accuracy for det ect ion of cert ain anomalies, part icularly PFO and ASA, due t o improvement s in scanner and t ransducer t echnology and in t echniques.
There is cont roversy concerning t he signifi cance of many TEE fi ndings (part icularly PFO, ASA and aort ic plaques) as a cause of st roke or TIA 9,15-17 , and t he ideal t reat ment for secondary prevent ion in t hese pat ient s, part icularly t hose wit h PFO or aort ic at heromas, has been debat ed at lengt h. Alt hough recent guidelines favor ant iplat elet t herapy over oral ant icoagulat ion in pat ient s wit h crypt ogenic MI: myocardial infarct ion; TIA: t ransient ischemic at t ack. st roke and PFO, t his is a suggest ion rat her t han a st rong recommendat ion in view of t he conflict ing evidence 18 . Similarly, t here have been no randomized t rials assessing ant it hrombot ic t herapy in pat ient s wit h aort ic plaques, and current guidelines generally favor ant iplat elet t herapy, wit h oral ant icoagulat ion being reserved for pat ient s wit h mobile aort ic arch t hrombi 18 . In our st udy, t he presence of any one of t he findings defi ned as a pot ent ial embolic source was shown t o be an independent predict or of t reat ment wit h oral ant icoagulat ion (OR=2.48; 95 % CI: 1.42-4.34; p=0.001). This is in agreement wit h ot her aut hors who found t hat TEE fi ndings infl uenced t he t herapeut ic st rat egy adopt ed, part icularly in younger pat ient s 4, 19 .
In our populat ion, TEE fi ndings also led t o percut aneous PFO closure in eight pat ient s (13.6 % of t hose wit h PFO). Alt hough t he number of such procedures is increasing, evidence t o support an invasive st rat egy is sparse 18 . The result s of t he CLOSURE I t rial, t he fi rst randomized st udy t o compare percut aneous PFO closure wit h medical t herapy for secondary prevent ion of st roke and TIA, were recent ly present ed and showed t hat percut aneous closure was not superior t o medical t herapy 20 . Ot her randomized st udies on t his subj ect are current ly in progress, namely t he CLOSE, PC, RESPECT and REDUCE t rials, and will no doubt provide new insight s.
It should be borne in mind t hat since t he present st udy covers a period of 18 years (1992-2009), t he t herapies described are not necessarily t hose current ly recommended but rat her a combinat ion of t he different t herapies t hat were considered appropriat e at part icular t imes for part icular pat ient s. There have been various changes over t his period in t he light of available evidence and guidelines for t he t herapeut ic management of t hese pat ient s, which has been t he subj ect of considerable debat e for t he last 20 years.
However, despit e t he uncert aint y and cont roversy surrounding t he most appropriat e t reat ment for cert ain anomalies, it was found t hat TEE findings influenced t he t herapeut ic st rat egy in t he period under analysis, confi rming t he import ant role of TEE in st roke and TIA in younger pat ient s.
Study limitations
Cert ain limit at ions should be borne in mind when int erpret ing t his st udy. Since it was a ret rospect ive, non-randomized st udy conduct ed in a single cent er, t he result s may have been infl uenced by known and unknown confounding fact ors. Due t o t he impossibilit y of accurat ely quant ifying aort ic plaque size from t he medical records, t he fi gure used in t he analysis (>2 mm) differs from t he size generally accept ed as represent ing a signifi cant embolic risk 14, 21 . Nevert heless, our result s in t his respect do not differ from t he fi ndings of ot her aut hors 10 .
Conclusions
In t he present st udy of pat ient s aged under 65 wit h st roke or TIA of no apparent cause aft er ECG, carot id ult rasound and TTE, t ransesophageal echocardiography ident ifi ed pot ent ial cardioembolic sources in a large number of pat ient s.
It was also found t hat TEE fi ndings had an independent influence on choice of t herapeut ic st rat egy (oral ant icoagulat ion or ant iplat elet t herapy), support ing t he role of TEE in t he assessment of younger pat ient s wit h st roke or TIA of no apparent cause aft er ECG and carot id ult rasound.
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